Valuation: Cipla Limited

Market Cap 1,075B 11.35B 10.13B 9.35B 8.49B 15.93B 16.18B 113B 44.36B 563B 42.61B 41.69B 1,784B P/E 2027 *
26x
P/E 2028 * 20.9x
Enterprise Value 969B 10.23B 9.13B 8.42B 7.65B 14.36B 14.58B 101B 39.98B 508B 38.4B 37.58B 1,608B EV / Sales 2027 *
3.13x
EV / Sales 2028 * 2.72x
Free-Float
68.87%
Yield 2027 *
0.98%
Yield 2028 * 1.11%
1 day+1.29%
1 week+0.22%
Current month-1.12%
1 month-3.84%
3 months-5.95%
6 months+7.65%
Current year-11.94%
1 week 1,296.4
Extreme 1296.4
1,339
1 month 1,292
Extreme 1292
1,421
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,625.1
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 31/03/2026
Director of Finance/CFO - 23/07/2026
President - 17/05/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 24/07/2014
Director/Board Member 71 29/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
22/08/24 Sell 2,000 0.0002%
14/08/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.29%+0.22%-20.00%+10.89% 11.25B
+2.83%+4.40%+60.84%+123.50% 1,133B
+3.81%+5.66%+38.70%+74.91% 621B
+0.14%+0.63%+24.71%+95.03% 503B
+0.03%+3.27%+39.79%+64.06% 379B
-1.76%+1.41%+68.06%+43.41% 370B
+1.58%+2.37%+22.91%+51.98% 292B
+2.90%+2.22%+3.51%+24.45% 262B
+2.04%+3.05%+51.12%+60.42% 237B
+2.36%-0.11%+29.42%+102.04% 190B
Average +1.70%+1.96%+31.91%+65.07% 399.92B
Weighted average by Cap. +1.96%+2.58%+42.70%+82.53%

Financials

2027 *2028 *
Net sales 309B 3.27B 2.91B 2.69B 2.44B 4.58B 4.65B 32.39B 12.76B 162B 12.26B 11.99B 513B 347B 3.66B 3.27B 3.02B 2.74B 5.14B 5.22B 36.32B 14.31B 182B 13.74B 13.45B 576B
Net income 41.18B 435M 388M 358M 325M 610M 620M 4.31B 1.7B 21.58B 1.63B 1.6B 68.35B 51.59B 545M 486M 448M 407M 764M 776M 5.4B 2.13B 27.03B 2.04B 2B 85.63B
Net Debt -106B -1.12B -1B -922M -838M -1.57B -1.6B -11.11B -4.38B -55.59B -4.2B -4.11B -176B -131B -1.39B -1.24B -1.14B -1.04B -1.95B -1.98B -13.77B -5.42B -68.87B -5.21B -5.1B -218B
Projected Income Statement - Annual - Cipla Limited
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
22/10/26 ₹1,330.90 +1.29% 638,943
21/10/26 ₹1,314.00 -0.76% 1,238,869
19/10/26 ₹1,324.10 -0.08% 1,387,215
16/10/26 ₹1,325.10 -0.22% 850,284
15/10/26 ₹1,328.00 +1.02% 1,371,747
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Cipla Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,330.90INR
Average target price
1,512.19INR
Spread / Average Target
+13.62%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cipla Limited
  1. Stock Market
  2. Stocks
  3. CIPLA Stock